Pharmaceutical research firm PPD explores sale, IPO: Reuters

Contract research organization Pharmaceutical Product Development LLC (PPD) is exploring a sale or initial public offering that could value it at between $7 billion and $8 billion, Reuters News reported.

DealsNorth AmericaUSBriefs